Biotech, and pathogen resistance

Diseased leaves from a potato late-blight field trial (source: Jonathan Jones).

Plant pathogens cause global crop losses of 15% every year, and are managed either by the use of resistant varieties or by pesticides. A trio of papers from The Sainsbury lab in the UK provides evidence that biotech approaches to engineering pathogen resistance could underpin sustainable genetic solutions to crop pests and pathogens. In one report, soybean is made resistant to Asian soybean rust using a gene cloned from the orphan legume pigeonpea. This finding is notable because Asian soybean rust resistance is absent from all commercially grown soybean lines. Plus, finding disease resistance genes that work in soybean in pigeonpea means that legumes could contain a reservoir of pathogen-resistance genes. In two accompanying reports, resistance genes for potato late-blight and wheat stem rust were identified by developing rapid resistance-gene cloning methods.

This research was funded in part by the 2Blades Foundation.

Posted in Uncategorized

A Cassava Genome Resource

Cassava

Cassava root from Uganda with necrotic brown lesions, characteristic of Cassava Brown Streak Disease.(source: Steve Rounsley, Dow AgriSciences)

Cassava is an important (but poorly performing) staple crop in Africa and other tropical countries. Although cassava can outcross, most cultivated cassava is clonally propagated, owing in part to long breeding cycles. Cassava is susceptible to disease, but the available germplasm is of limited diversity, so breeders need genomic sources of diversity to improve this vital crop. Daniel Rokhsar (University of California, Berkeley and DOE JGI), Steve Rounsley (Dow Agrosciences) and colleagues sequenced nearly 60 cultivated cassava and wild relatives and genotyped more than 250 African accessions to provide a Cassava genome resource that will support genome-enabled improvement. Their paper can be found here online, and in the coming May issue of Nature Biotechnology.

Posted in Uncategorized

Most cited papers: bioengineering and agbiotech

NBTat20

We list below the highest-cited papers focusing on bioengineering (metabolic engineering, synthetic biology and bioengineering) and agbiotech from the past 20 years. We recognize there are many more ways to assess the quality/impact of the research published in our pages than citations, but we hope our readers find this of interest. Do you see any higher citing papers we missed in each of these areas? Comments below, or tweet at us: @naturebiotech.

 

 

Bioengineering

AgbiotechCitation data from ISI Thomson Reuters Web of Science

Posted in Uncategorized

Most cited papers: Microbial technologies and the microbiome, and immunotechnology

NBTat20

 

We list below the highest cited papers focusing on applied microbiology and immunology from the past 20 years. We recognize there are many more ways to assess the quality/impact of the research published in our pages than citations, but we hope our readers find this of interest. Do you see any higher citing papers we missed in each of these areas? Comments below, or tweet at us: @naturebiotech

 

Microbial technologies and the microbiome

ImmunotechnologyCitation data from ISI Thomson Reuters Web of Science

Posted in Uncategorized

Most cited papers: nanotechnology and cancer technologies

NBTat20Nature Biotechnology is 20! We list below the highest cited papers focusing on nanotechnology and cancer technologies from the past 20 years. We recognize there are many more ways to assess the quality/impact of the research published in our pages than citations, but we hope our readers find this of interest. Do you see any higher citing papers we missed in each of these areas? Comments below, or tweet at us: @naturebiotech

 

 

Nanotechnology

Cancer technologiesCitation data from ISI Thomson Reuters Web of Science

Posted in Uncategorized

Most cited papers: protein engineering and genetic engineering

NBTat20Nature Biotechnology is 20! We list below the highest cited papers focusing on protein and genetic engineering from the past 20 years. We recognize there are many more ways to assess the quality/impact of the research published in our pages than citations, but we hope our readers find this of interest. Do you see any higher citing papers we missed in each of these areas? Comment below, or tweet at us: @naturebiotech.

 

 

Protein engineering

Genetic engineeringCitation data from ISI Thomson Reuters Web of Science

Posted in Uncategorized

Most cited papers: biologic therapies, nucleic acid therapies and drug delivery

NBTat20Nature Biotechnology is 20! We list below the highest cited papers focusing on biologics, nucleic acid therapies and drug delivery from the past 20 years. We recognize there are many more ways to assess the quality/impact of the research published in our pages than citations, but we hope our readers find this of interest. Do you see any higher citing papers we missed in each of these areas? Comments below, or tweet at us: @naturebiotech

 

 

Biologic therapies

Nucleic acid therapies

Drug delivery technologyCitation data from ISI Thomson Reuters Web of Science

Posted in Uncategorized

Most cited papers: regenerative medicine and biomaterials

NBTat20Nature Biotechnology is 20! We list below the highest cited papers focusing on regenerative medicine and biomaterials from the past 20 years. We recognize there are many more ways to assess the quality/impact of the research published in our pages than citations, but we hope our readers find this of interest. Do you see any higher citing papers we missed in each of these areas? Comments below, or tweet at us: @naturebiotech

 

 

Regenerative medicine

BiomaterialsCitation data from ISI Thomson Reuters Web of Science

Posted in Uncategorized